Title : A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy.

Pub. Date : 2021 Jan 16

PMID : 33467104






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Flavocoxid induced a significant reduction in serum interleukin (IL)-1 beta and TNF-alpha only in the group of DMD boys on add-on therapy (flavocoxid added to steroids for at least six months). flavocoxid interleukin 1 alpha Homo sapiens